Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
McDermott, D., Haanen, J., Chen, T.- T., Lorigan, P., O'Day, S.Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt291
Date:
October, 2013
File:
PDF, 90 KB
english, 2013